Quantitative spectral electroencephalography in predicting survival in patients with early Alzheimer disease

Archives of Neurology

Volumn 55, Issue 8, 1998, Pages 1105-1111

  Claus, Jules J ^a,b   Ongerboer De Visser, Bram W ^a   Walstra, Gerard J M ^a   Hijdra, Albert ^a   Verbeeten Jr , Bernard ^a   Van Gool, Willem A ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALPHA RHYTHM; ALZHEIMER DISEASE; ARTICLE; BETA RHYTHM; BRAIN CORTEX ATROPHY; COGNITION; COHORT ANALYSIS; DISEASE SEVERITY; ELECTROENCEPHALOGRAPHY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HALLUCINATION; HUMAN; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; RISK FACTOR; SURVIVAL TIME; THETA RHYTHM;

AGED; ALZHEIMER DISEASE; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK; SURVIVAL ANALYSIS;

EID: 3543002838     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.55.8.1105     Document Type: Article

References (47)

1. Coben LA, Danziger W, Storandt M. A longitudinal EEG study of mild senile dementia of Alzheimer type: changes at 1 year and at 2.5 years. Electroencephalogr Clin Neurophysiol. 1985;61:101-112.
2. Penttila M, Partanen JV, Soininen H, Riekkinen PJ. Quantitative analysis of occipital EEG in different stages of Alzheimer's disease. Electroencephalogr Clin Neurophysiol. 1985;60:1-6.
3. Soininen H, Partanen J, Laulumaa V, Paakkonen A, Helkala E-L, Riekkinen PJ. Serial EEG in Alzheimer's disease: 3 year follow-up and clinical outcome. Electroencephalogr Clin Neurophysiol. 1991;79:342-348.
4. Schreiter-Gasser U, Gasser T, Ziegler P. Quantitative EEG analysis in early onset Alzheimer's disease: correlations with severity, clinical characteristics, visual EEG and CCT. Electroencephalogr Clin Neurophysiol. 1994;90:267-272.
5. Prichep LS, John ER, Ferris SH, et al. Quantitative EEG correlates of cognitive deterioration in the elderly. Neurobiol Aging. 1994;15:85-90.
6. Claus JJ, Kwa VIH, Teunisse S, et al. Slowing on quantitative spectral EEG is a marker for rate of subsequent cognitive and functional decline in early Alzheimer's disease. Alzheimer Dis Assoc Disord. In press.
7. Kuskowski MA, Mortimer JA, Morley GK, Malone SM, Okaya AJ. Rate of cognitive decline in Alzheimer's disease is associated with EEG alpha power. Biol Psychiatry. 1993;33:659-662.
8. Lopez OL, Brenner RP, Becker JT, Ulrich RF, Boller F, DeKosky ST. EEG spectral abnormalities and psychosis as predictors of cognitive and functional decline in probable Alzheimer's disease. Neurology. 1997;48:1521-1525.
9. Rodriguez G, Nobili F, Arrigo A, et al. Prognostic significance of quantitative electroencephalography in Alzheimer patients: preliminary observations. Electroencephalogr Clin Neurophysiol. 1996;99:123-128.
10. Kaszniak AW, Fox J, Gandell JL, Garron DC, Huckman MS, Ramsey RG. Predictors of mortality in presenile and senile dementia. Ann Neurol. 1978;3:246-252.
11. Helkala E-L, Laulumaa V, Soininen H, Partanen J, Riekkinen PJ. Different patterns of cognitive decline related to normal or deteriorating EEG in a 3-year follow-up study of patients with Alzheimer's disease. Neurology. 1991;41:528-532.
12. Saletu B, Anderer P, Paulus E, et al. EEG brain mapping in diagnostic and therapeutic assessment of dementia. Alzheimer Dis Assoc Disord. 1991;5(suppl 1):S57-S75.
13. Lopez OL, Brenner RP, Becker JT, Jungreis C, Rezek D, DeKosky ST. Electroencephalographic correlates of periventricular white matter lesions in probable Alzheimer's disease. Dementia. 1995;6:343-347.
14. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services task force on Alzheimer's disease. Neurology. 1984;34:939-944.
15. Walstra GJM, Teunisse S, van Gool WA, van Crevel H. Reversible dementia in elderly patients referred to a memory clinic. J Neurol. 1997;244:17-22.
16. Derix MM, Hofstede AB, Teunisse S, et al. CAMDEX-N: the Dutch version of the Cambridge Examination for Mental Disorders of the Elderly with automatic data processing. Tijdschr Gerontol Geriatr. 1991;22:143-150.
17. Roth M, Huppert FA, Tym E, Mountjoy CQ. CAMDEX, the Cambridge Examination for Mental Disorders of the Elderly. Cambridge, England: Cambridge University Press; 1988.
18. 12: effects of replacement therapy on severity of dementia. J Neurol. 1996;243:522-529.
19. John ER, Prichep LS, Fridman J, Easton P. Neurometrics: computer-assisted differential diagnosis of brain dysfunctions. Science. 1988;239:162-169.
20. John ER, Ann H, Prichep LS, Trepetin M, Brown P, Kaye H. Development equations for the electroencephalogram. Science. 1980;210:1255-1258.
21. Hijdra A, Verbeeten BJ. Leukoaraiosis and ventricular enlargement in patients with ischemic stroke. Stroke. 1991;22:447-450.
22. Hijdra A, Verbeeten BJ, Verhulst JAPM. Relation of leukoaraiosis to lesion type in stroke patients. Stroke. 1990;21:890-894.
23. Waldemar G, Bruhn P, Kristensen M, Johnson A, Paulson OB, Lassen NA. Heterogeneity of neocortical cerebral blood flow deficits in dementia of the Alzheimer type: a [99mTc]-d,I-HMPAO SPECT study. J Neurol Neurosurg Psychiatry. 1994;57:285-295.
24. Jacoby RJ, Levy R, Dawson JM. Computed tomography in the elderly, I: the normal population. Br J Psychiatry. 1997;136:249-255.
25. Collet D. Modelling Survival Data in Medical Research. London, England: Chapman & Hall; 1994.
26. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12:189-198.
27. McKeith IG. Lewy body disease. Curr Opin Psychiatry. 1995;8:252-257.
28. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47:1113-1124.
29. Petit D, Montplaisir J, Lorrain D, Gauthier S. Spectral analysis of the rapid eye movement sleep electroencephalogram in right and left temporal regions: a biological marker of Alzheimer's disease. Ann Neurol. 1992;32:172-176.
30. Soininen H, Partanen VJ, Laulumaa V, Helkala E-L, Laakso M, Riekkinen PJ. Longitudinal EEG spectral analysis in early stage of Alzheimer's disease. Electroencephalogr Clin Neurophysiol. 1989;72:290-297.
31. Steriade M, Gloor P, Llinas RR, Lopez da Silva FH, Mesulam M-M. Report of IFCN Committee on Basic Mechanisms: basic mechanisms of cerebral rhythmic activities. Electroencephalogr Clin Neurophysiol. 1990;76:481-508.
32. Steriade M. Cellular substrates of brain rhythms. In: Niedermeyer E, Lopes da Silva F, eds. Electroencephalograpy: Basic Principles, Clinical Applications, and Related Fields. Baltimore, Md: Williams & Wilkins; 1993:27-62.
33. Heyman A, Peterson B, Fillenbaum G, Pieper C. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), part XIV: demographic and clinical predictors of survival in patients with Alzheimer's disease. Neurology. 1996;46: 656-660.
34. Burns A, Lewis G, Jacoby R, et al. Factors affecting survival in Alzheimer's disease. Psychol Med. 1991;21:363-370.
35. Jagger C, Clarke M, Stone A. Predictors of survival with Alzheimer's disease: a community-based study. Psychol Med. 1995;25:171-177.
36. Walsh JS, Welch G, Larson EB. Survival of outpatients with Alzheimer-type dementia. Ann Intern Med. 1990;113:429-434.
37. Leung LS. Fast (beta) rhythms in the hippocampus: a review. Hippocampus. 1992; 2:93-98.
38. Riekkinen PJ, Riekkinen M, Sirvio J, Miettinen R, Koudstaal PJ. Loss of cholinergic neurons in the nucleus basalis induces neocortical electroencephalographic and passive avoidance deficits. Neuroscience. 1992;47:823-831.
39. Boeijinga PH, Lopez da Silva FH. Differential distribution of beta and theta EEG activity in the entorhinal cortex of the cat. Brain Res. 1988;448:272-286.
40. Gomez-Isla T, Price JL, McKeel DW Jr, Morris JC, Growden JH, Hyman BT. Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J Neurosci. 1996;16:491-500.
41. Heinonen O, Soininen H, Sorvari H, et al. Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's disease. Neuroscience. 1995;64:375-384.
42. Williamson PC, Merskey H, Morrison S, et al. Quantitative electroencephalographic correlates of cognitive decline in normal elderly subjects. Arch Neurol. 1990;47:1185-1188.
43. Hofman A, Ott A, Breteler MMB, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet. 1997; 349:151-154.
44. Jelic V, Julin P, Shigeta M, et al. Apolipoprotein E ∈4 allele decreases functional connectivity in Alzheimer's disease as measured by EEG coherence. J Neurol Neurosurg Psychiatry. 1997;63:59-65.
45. Tanna NK, Kohn MI, Horwich DN, et al. Analysis of brain and cerebrospinal fluid volumes with MR imaging: impact on PET data correction for atrophy, part II: aging and Alzheimer dementia. Radiology. 1991;178:123-130.
46. Stern Y, Tang M-X, Albert MS, et al. Predicting time to nursing home care and death in individuals with Alzheimer's disease. JAMA. 1997;277:806-812.
47. Stern Y, Brandt J, Albert M, et al. The absence of an apolipoprotein epsilon4 allele is associated with a more aggressive form of Alzheimer's disease. Ann Neurol. 1997;41:615-620.